Emerging risks | Growth Opportunities | APAC Insurance

Wednesday, August 5, 2026

Manulife brings Guardant Health’s Shield MCD cancer screening to Hong Kong, Philippines, and Singapore

The Shield MCD test screens for 10 of the most common cancers — bladder, colorectal, breast, prostate, esophageal, gastric, liver, lung, ovarian, and pancreatic — with just a blood draw.
March 17, 2026

 • 

2 min read
The Inaugural Recognising excellence in Asia's insurance industry Find out more Entries close
28 August
Banner for 22nd SIRC: 'Capacity to Capability'—Building resilience through innovation; futuristic city skyline with a glowing highway; Nov 1–5, 2026 at Sands Expo & Convention Centre.
Already a member? Sign in →
MEMBERS ONLY
Continue reading with a free account.
• Free daily briefing in your inbox each morning
• 14 day trial to (Re)in Asia's premium intelligence
• No credit card required
The Inaugural Recognising excellence in Asia's insurance industry Find out more Entries close
28 August
Banner for 22nd SIRC: 'Capacity to Capability'—Building resilience through innovation; futuristic city skyline with a glowing highway; Nov 1–5, 2026 at Sands Expo & Convention Centre.